NCT06321510View on ClinicalTrials.gov

A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

Active, not recruitingOBSERVATIONAL

Enrollment

29

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Lung Cancer

Trial Locations (1)

11490, R.O.C.

Tri-Service General Hospital, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY